Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization

The combination of filgrastim (G-CSF) and plerixafor is currently approved for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin lymphoma and multiple myeloma undergoing autologous peripheral blood hematopoietic cell transplantation. However, chemotherapy and G-CSF-based mobi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Awan, Farrukh T., Kochuparambil, S. Thomas, DeRemer, David, Cumpston, Aaron, Craig, Michael, Jillella, Anand, Hamadani, Mehdi
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3335320/
https://ncbi.nlm.nih.gov/pubmed/22570654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/931071
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars